US20110092854A1 - Instruments and system for producing a sample of a body fluid and for analysis thereof - Google Patents
Instruments and system for producing a sample of a body fluid and for analysis thereof Download PDFInfo
- Publication number
- US20110092854A1 US20110092854A1 US12/582,277 US58227709A US2011092854A1 US 20110092854 A1 US20110092854 A1 US 20110092854A1 US 58227709 A US58227709 A US 58227709A US 2011092854 A1 US2011092854 A1 US 2011092854A1
- Authority
- US
- United States
- Prior art keywords
- pressure ring
- skin
- pressing force
- lancing
- instrument according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 93
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 54
- 239000010839 body fluid Substances 0.000 title claims abstract description 54
- 238000003825 pressing Methods 0.000 claims abstract description 80
- 230000001737 promoting effect Effects 0.000 claims abstract 4
- 230000003993 interaction Effects 0.000 claims description 32
- 238000006073 displacement reaction Methods 0.000 claims description 25
- 238000005259 measurement Methods 0.000 claims description 20
- 230000035515 penetration Effects 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 230000006835 compression Effects 0.000 claims description 4
- 238000007906 compression Methods 0.000 claims description 4
- 238000005070 sampling Methods 0.000 claims description 2
- 238000013461 design Methods 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000012491 analyte Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010291 electrical method Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000012432 intermediate storage Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
- A61B5/15188—Constructional features of reusable driving devices
- A61B5/1519—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
- A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150068—Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
- A61B5/150419—Pointed piercing elements, e.g. needles, lancets for piercing the skin comprising means for capillary action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
- A61B5/150435—Specific design of proximal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150801—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
- A61B5/150809—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150801—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
- A61B5/150816—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by tactile feedback, e.g. vibration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150954—Means for the detection of operative contact with patient, e.g. by temperature sensitive sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15107—Piercing being assisted by a triggering mechanism
- A61B5/15109—Fully automatically triggered, i.e. the triggering does not require a deliberate action by the user, e.g. by contact with the patient's skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
- A61B5/15123—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising magnets or solenoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15126—Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
- A61B5/15128—Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides comprising 2D- or 3D-shaped elements, e.g. cams, curved guide rails or threads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
- A61B5/15188—Constructional features of reusable driving devices
- A61B5/15192—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing
- A61B5/15194—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing fully automatically retracted, i.e. the retraction does not require a deliberate action by the user, e.g. by terminating the contact with the patient's skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150175—Adjustment of penetration depth
- A61B5/150183—Depth adjustment mechanism using end caps mounted at the distal end of the sampling device, i.e. the end-caps are adjustably positioned relative to the piercing device housing for example by rotating or screwing
Definitions
- the present disclosure generally relates to the collection of body fluid for analysis, i.e., the determination of an analyte concentration therein and, in particular, relates to instruments and systems for producing a small body fluid sample by piercing the skin of a subject (human or animal) using a disposable lancing element having a skin piercing tip suitable for generating a small wound from which the sample is drawn.
- a disposable lancing element having a skin piercing tip suitable for generating a small wound from which the sample is drawn.
- the body fluid is blood or interstitial fluid or a mixture thereof.
- home-monitoring refers, for example, to the regular control of blood cholesterol and to the control of blood coagulation parameters.
- the present disclosure may be particularly suitable, but not limited, to home-monitoring applications. Similar requirements may also exist, e.g., in so-called “near-patient-testing.”
- Lancing of the skin is generally performed by a lancing system comprising, as mutually adapted components of the system, a reusable hand-held instrument and lancing elements.
- the movement for lancing i.e., puncturing movement
- a lancing drive provided inside a housing of the instrument and adapted for driving a lancing element connected thereto.
- Lancets can be interchangeably connected to the drive and generally are disposable items.
- the lancet After triggering the puncturing movement, the lancet is driven in a puncture direction until it reaches a point of maximum displacement and thereafter it is further driven in a reverse direction.
- the driving force is supplied by a tensioned spring and the lancet drive further includes suitable mechanical means for converting the force of the spring into the required movement of a lancet.
- the analysis generally required a plurality of steps to be performed by the user.
- the body fluid sample typically did not readily emanate from the wound site in the lanced skin. Therefore, manual “milking” steps such as pinching, squeezing and kneading where necessary in order to express the required amount of body fluid sample.
- the body fluid sample was contacted to an analysis element of an analysis system, which typically was separate and distinct from the lancing system, and the analysis was performed thereby.
- the skin contact opening has a relatively large diameter whereby the skin bulges into the skin contact opening forming a target site bulge which penetrates to some extent into the opening when the lancing instrument is pressed with its distal end, i.e., with the skin contact surface, against the skin.
- This bulging action hereafter designated “target site bulging,” is generally combined with additional methods for improving body fluid sample production, such as, for example, a mechanical squeezing acting radially inwardly, a pumping action involving axial movement of parts of the instrument, etc.
- target site bulging occurs when a lancing instrument is pressed against the skin, or vice versa, at the lancing site. While this bulging is favorable regarding expression of a sufficient amount of body fluid sample, it may cause a problem regarding reproducibility of the penetration depth by which the tip of the lancing element penetrates into the skin.
- z-position position in the direction of the lancing movement
- the lancing drive and consequently a given z-position of the point of maximum displacement of the lancet the penetration depth depends on the exact z-position of the skin surface during the puncturing movement. Due to the bulging of this skin, position is substantially undefined.
- the duration of the minimum interaction time period can be highly critical. This time period can be defined as the minimum time duration for which user-instrument interaction can be required for lancing and for collecting a sufficient amount of sample for the analysis in a sample collection device of the system.
- the functions performed during the MITP can include lancing, expression of body fluid sample from the tissue, preferably directly into a capillary of the lancing element, and collecting a sufficient amount of sample.
- the MITP can be a system-related quantity which can be user-independent, i.e., only determined by the design of the instrument, and possibly by other components of the system. It may not be confused with the actual time of interaction which in each case can depend on numerous aspects including the habits of the user. The actual interaction time generally can vary between users and, even for a specific user, from analysis to analysis.
- the present disclosure can design the system in such a manner, that the minimum time for which every user must at least interact with the instrument, can be below the indicated very small threshold values.
- an instrument and a system for producing a sample of body fluid by piercing the skin can comprise a housing, a lancing drive within the housing adapted for being connected to a lancing element and adapted for driving a lancing element connected thereto in a puncturing movement in which the lancing element moves, after triggering the puncturing movement, in a puncture direction until it reaches a point of maximum displacement and in a reverse direction after it has reached the point of maximum displacement, and a pressure ring surrounding a skin contact opening and being adapted for being pressed against the skin such that the skin bulges into the opening whereby expression of body fluid is promoted after the piercing tip of a lancing element has pierced the skin.
- the skin contact opening can have an opening area corresponding to a circle with a diameter of at least about 3 mm and at most about 8 mm.
- the instrument can include a pressing force control device for controlling the force acting between the pressure ring and the skin (“pressing force”) at the time of triggering the puncturing movement, to be at least about 3 N and at most about 8 N.
- the system and an instrument for producing a sample of body fluid by piercing the skin can use a lancing element having a skin piercing tip and, for analysis, can use a disposable analysis element.
- the instrument can comprise a housing, a lancing drive within the housing adapted for being connected to a lancing element and adapted for driving a lancing element connected thereto in a puncturing movement in which the lancing element moves, after triggering the puncturing movement, in a puncture direction until it reaches a point of maximum displacement and in a reverse direction after it has reached the point of maximum displacement, a pressure ring surrounding a skin contact opening and being adapted for being pressed against the skin such that the skin bulges into the opening whereby expression of body fluid is promoted after the piercing tip of a lancing element has pierced the skin, and a holding device adapted for holding an analysis element in the housing such that a sample of body fluid produced by piercing the skin can be transported thereto for analysis.
- the user can interact with the system by establishing a pressing force between the skin and the pressure ring of the instrument by pressing the hand-held instrument against the finger or other body part.
- the finger or other body part can be pressed against the instrument by, for example, lying on a table.
- FIG. 1 illustrates a schematic sketch relating to the principles of target site bulging according to an embodiment of the present disclosure.
- FIG. 2 illustrates a perspective view of an analysis instrument according to an embodiment of the present disclosure.
- FIG. 3 illustrates a longitudinal section of the instrument shown in FIG. 2 according to an embodiment of the present disclosure.
- FIG. 4 illustrates a perspective view of a lancing element for use in the instrument shown in FIG. 3 according to an embodiment of the present disclosure.
- FIG. 5 illustrates a schematic sketch regarding an aspect of the function of the instrument shown in FIG. 3 according to an embodiment of the present disclosure.
- FIG. 1 illustrates symbolically the point P of maximum displacement which a piercing tip 7 reaches on its movement path during the puncturing movement.
- the sample collection device 36 can belong to the analysis unit. It can be a part of an analysis element 21 , or of a dedicated sample collection element, and can collect body fluid sample after the analysis unit has been moved to the skin contact opening 4 .
- a “single unit system,” the sample collection device 36 can be a part of a lance element, a part of an analysis element 21 , a part of an integrated lancing and analysis element 22 or a part of a dedicated sample collection element.
- sample collection device 36 is a part of an analysis element 21 , or of an integrated lancing and analysis element 22 , it can, in particular, be a part of a reaction zone thereof containing reagents which react with the body fluid sample, thereby producing some kind of measurable physical change which can be characteristic for the analysis.
- the sample collection device 36 can be separate from the reaction zone of the analysis element 21 and can include a reservoir, which can be suitable for storing a body fluid sample for an intermediate storage time which may be longer than the minimum interaction time period (“MITP”).
- MITP minimum interaction time period
- One advantage of this embodiment can be that it can allow to separate the timing requirements of the sample collection from the timing requirements of the analysis.
- the MITP can be terminated as soon as the reservoir of the sample collection device 36 contains a sufficient amount of body fluid sample for the analysis. Further steps, including, for example, the filling of a reaction zone, can take place separately without continued interaction of the user.
- the transfer of the body fluid sample from the reservoir of the sample collection device 36 to the reaction zone of the analysis element 21 can either take place spontaneously or with controlled timing.
- the fluid communication from the reservoir of the sample collection device 36 to the analysis element 21 can be “switchable,” i.e., initially, preferably at least for the duration of the MITP, there may be no fluid communication but same may be established in a controlled manner at a suitable point of time. Suitable methods for such switching are well known in the art.
- the z-positions of the plane of the pressure ring 1 and the point of maximum displacement P relative to each other shown as distance s FIG. 1 , can be adjusted in order to allow a penetration depth setting.
- FIG. 1 illustrates, that for a given value of this adjustment, the actual penetration depth x can depend directly on the distance d, i.e., the degree of target site bulging 6 .
- the degree of target site bulging 6 i.e., the distance d between the plane of pressure ring 1 and the apex of target site bulge 6 , can be influenced by many factors such as, for example, the size of the skin contact opening 4 , the pressing force F and the viscoelastic properties of the skin 3 .
- the skin contact opening 4 can be substantially circular. In one embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 3 mm to about 8 mm. In another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 4 mm to about 7 mm. In yet another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 5 mm to about 6.5 mm. In still another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 5.5 mm to about 6 mm.
- the area of the skin contact opening 4 can substantially correspond, i.e., be about the same, as the area of a circle with the above mentioned diameter values.
- the smallest inner, free width of a non-circular skin contact opening 4 can be at least about 3 mm. In another embodiment, the smallest inner, free width of a non-circular skin contact opening 4 can be at least about 4 mm.
- the uncertainty about the actual z-position of the skin 3 i.e., the apex of the target site bulge 6
- the present disclosure has surprisingly found that a very good reproducibility of the penetration depth during lancing can be achieved if the specified conditions concerning the area of the skin contact opening 4 and the amount of the pressing force F are maintained.
- FIGS. 2-5 illustrate an exemplary lancing system 10 .
- the lancing system 10 can include a reusable hand-held instrument 11 and a disposable lancing element 12 with a piercing tip 7 .
- a housing 13 of the instrument 11 can contain a lancing drive 14 and a measurement and evaluation electronics 15 , shown symbolically in FIG. 3 .
- a display 16 can be provided to the user in order to allow visual indication of information including, for example, status information concerning the lancing system 10 , advice concerning its handling, analytical results and any other suitable information.
- the instrument 11 also can comprise a MITP controlling device 17 , a device 18 for generating audible signals such as, for example, a buzzer, and/or a device 19 for generating tactile signals such as, for example, a vibration generator.
- a MITP controlling device 17 a device 18 for generating audible signals such as, for example, a buzzer, and/or a device 19 for generating tactile signals such as, for example, a vibration generator.
- a lancing element 12 can be combined with an analysis element 21 to form an integral lancing and analysis element 22 .
- the lancing element 12 can be movable in a longitudinal direction symbolized by the double arrow 34 .
- An analysis element holder 20 can be provided for holding the analysis element 21 inside the instrument 11 .
- the analysis element holder 20 can comprise a coupling recess 25 in the analysis element 21 and a corresponding coupling protrusion 27 of the instrument 11 .
- the lancing element 12 can have a coupling recess 24 cooperating with a coupling protrusion 26 of the instrument 11 .
- the lancet drive 14 shown in FIG. 3 , can comprises a drive rotor 29 with a cam 30 formed by a groove.
- the cam 30 and a corresponding cam traveler 31 can form a cam drive mechanism which can control a pivoting movement of a drive rod 32 about a pivoting axis 33 .
- the drive rotor 29 can turn with high speed, driven by a drive spring, about its axis 35 .
- This rotational movement can be translated by a cam curve formed by groove 30 and traveled by cam traveler 31 into a corresponding pivoting movement of drive rod 32 which again can drive a corresponding up and down movement of lancing element 12 to which it can be connected by its coupling protrusion 26 penetrating into coupling recess 24 .
- Similar drive rotor 29 for lancing instruments 11 are known in the art, therefore, no more detailed description may be necessary.
- the lancing element 12 can be a “direct sampler” having a capillary channel 28 inside its piercing tip 7 and leading up to a sample collection zone 23 of lancing element 12 .
- the capillary channel 28 can widen to form a sample reservoir chamber 28 a.
- the lancing element 12 can perform a puncturing movement by which piercing tip 7 can be driven into skin 3 . Thereafter, during a retraction phase of the puncturing movement, after the piercing tip 7 has reached its point of maximum displacement P but with the piercing tip 7 still below the surface of skin 3 , a body fluid sample can penetrate, driven by capillary forces, into the capillary channel 28 and reservoir chamber 28 a .
- the capillary 28 and reservoir chamber 28 a together can form a sample collection device 36 suitable for storing body fluid sample, ready for subsequent transfer to an analysis zone 8 of analysis element 21 .
- the body fluid sample may be transferred to the adjacent analysis zone 8 of analysis element 21 by a suitable fluid communication device.
- the arrangement can be such that there can beno fluid communication between the sample collection zone 23 of lancing element 12 and the analysis element 21 .
- fluid communication can take place. The switching between the two embodiments can be accomplished by any suitable method known in the art such as, for example, by pressing sample collection zone 23 of lancing element 12 and analysis element 21 together.
- the present disclosure can also be used with integral lancing and analysis elements 22 having a lancing part and an analysis part fixed together.
- two separate holding devices may not be required. Instead, one holding device may be provided which simultaneously serves as lancing element 12 holding device and as analysis element holding device.
- Such devices can include, for example, a design in which analysis elements 21 and/or lancing elements 12 can be fixed to and transported by means of a tape during at least a part of the lancing system 10 operation.
- the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 3 N to about 8 N. In another embodiment, the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 4 N to about 7 N. In yet another embodiment, the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 5 N to about 6 N. A defined pressing force F within these limits can be ensured by a suitable pressing force control device 37 . The limiting values of the pressure force can be with respect to the requirements of withdrawing sample from the skin 3 .
- the pressing force F can be allowed to float in that range during the MITP. Rather, in one exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 15%. In another exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 10%. In yet another exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 5%. Expressed in absolute values, in one exemplary embodiment, the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/ ⁇ 0.5 N.
- the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/ ⁇ 0.3 N and, in yet another exemplary embodiment, the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/ ⁇ 0.2 N.
- the pressing force control device 37 can be mechanical, in particular, it can comprise a spring device 38 which can be arranged in such a manner that its spring force can act between the pressure ring 1 and the housing 13 .
- the spring device 38 can be a metal spring.
- Other suitable spring-like devices are, however, known in the art and can be used, such as, for example, a pneumatic spring or a resilient element of an elastic material.
- the term “spring” can be used as an example of any such spring device 38 .
- the spring device 38 can be pre-tensioned.
- pressing force control devices 37 operating by electrical methods may comprise an electromagnetic drive including a coil and a magnetic core, in particular a voice coil drive.
- the control of the pressure can be fully automatic or it can require an activity of the user.
- electrical methods can be used to measure the force by which the pressure ring 1 may be pressed against the skin 3 and this force can be indicated to the user by suitable visible, acoustic or tactile methods, whereby the user can adapt the pressing force F to the desired value.
- a special feature according to one embodiment of the present disclosure can relate to a pressing force control device 37 provided in the instrument 11 .
- the pressing force control device 37 can comprise a spring 38 which can be embodied and arranged in such a manner that one end thereof can act against pressure ring 1 and the other end can act against the housing 13 .
- the term “acting” in this context may not require immediate contact. Instead, it can mean that the spring can exert a force on the pressure ring 1 and that the corresponding counter-force can be, directly or indirectly, borne by the housing 13 .
- the instrument 11 shown in FIG. 3 , can comprise one end of spring 38 that can rest on a wall of housing 13 and another end that can press against a frame element 39 carrying lancing drive 14 .
- the force of spring 38 can be further transmitted from the frame element 39 to pressure ring 1 via pillar elements 40 .
- Pressure ring 1 can be embodied as part of a pressure piece 42 which can be borne by a pressure ring bearing 43 of housing 13 such that it can be axially movable against the force of spring 38 .
- FIG. 5 illustrates that the spring 38 can act between housing 13 and pressure piece 42 with pressure ring 1 .
- the lancing drive 14 can be connected in a defined spatial configuration with pressure ring 1 , in such a manner that the distance between the point of maximum displacement P of the lancet movement and the pressure ring 1 can be independent from the compression status of the spring 38 and the corresponding axial movement of pressure piece 42 .
- the spatial configuration and, hence, the distance of the pressure ring 1 from the point of maximum displacement P can be varied, between puncturing movements, to set the lancing penetration depth.
- it can be fixed during the interaction of the user with the device, i.e., from the point of time at which the pressure ring 1 can be first pressed down until the body part 2 is removed therefrom.
- the elastic spring 38 can increase linearly with its elongation, i.e., compression in the case of a compression spring as shown.
- the pressure ring 1 pressed against the skin 3 can be controlled closely, i.e., the variation thereof may not exceed the preferred limiting values.
- the spring 38 can be arranged in such a manner that it may be pre-tensioned. This means that the spring can already be compressed, or in the case of an extension spring can be extended, even if no pressing force F is exerted onto pressure ring 1 , i.e., the pressure ring 1 is in its “home” position resting on the surrounding wall, bearing 43 , of housing 13 .
- the degree of this pre-tensioning can be such that the force of spring 38 acting on the pressure ring 1 can vary by no more than about 20% within the spring-loaded movement range of the pressure ring 1 . In another exemplary embodiment, the force of spring 38 acting on the pressure ring 1 can vary by no more than about 10%.
- a pressure ring movement limiting arrangement 44 (see FIG. 5 ) can be provided by which the maximum displacement P of the pressure ring 1 possible by pressing with a finger 2 , or other body part, can be limited within a fully spring-loaded movement range of the pressure ring 1 .
- this can be achieved by a contact surface 46 which can be arranged in the vicinity, at the outer side, of the pressure ring 1 in such a manner that a body part pressed against the pressure ring 1 , and thereby moving the pressure ring 1 , can abut against the contact surface 46 . Due to this abutting, the pressure ring 1 cannot be moved further, i.e., the possible displacement of the pressure ring 1 , by the body part 2 pressing thereagainst, can be limited.
- the maximum displacement P can depend on the distance dr by which the pressure ring 1 can protrude from the instrument housing 13 , contact surface 46 . When pressure piece 42 with pressure ring 1 is pressed downwardly, this movement can be discontinued when finger tip 2 contacts the surface of housing 13 in the vicinity of the pressure ring 1 .
- the maximum displacement P of the pressure ring 1 during practical use may be small. In one embodiment, it can be less than about 3 mm. In another embodiment, it can be less than about 2 mm. In still another embodiment, it can be less than about 1 mm. Therefore, the distance dr of the plane of pressure ring 1 and the adjacent housing 13 surface, may not be too large. In one exemplary embodiment, maximum values can be calculated by adding approximately 0.5 mm to the mentioned maximum displacement P values.
- this protrusion i.e., the distance, dr, can be at least about 0.2 mm. In another embodiment, the distance, dr, can be at least about 0.5 mm.
- the pressure ring 1 may be non-deformable in the sense that it may not be visibly deformed during normal use of the lancing system 10 .
- a suitable exact shape and width of the pressure ring 1 can be determined experimentally.
- the pressure ring 1 can have a width of at most about 3.5 mm.
- the pressure ring 1 can have a width of at most about 2.5 mm.
- the pressure ring 1 can have a width of at most about 1 mm.
- the pressure ring 1 can have a minimum width of about 0.5 mm.
- the pressure ring 1 can have a minimum width of about 0.7 mm.
- the pressure ring 1 can have a minimum width of about 0.8 mm.
- the pressure ring 1 may protrude from any adjacent housing 13 surface by a sufficient distance to allow easy tactile recognition thereof by the user.
- the pressure ring 1 can have many different shapes and designs as known in the art.
- the term “pressure ring” can refer to the ring-shaped surface of the respective part which in practical use, i.e. under the conditions prevailing in using of the particular instrument 11 , can contact the skin 3 surface.
- this ring-shaped contact surface i.e., the pressure ring 1
- pressure ring may not be being limited to an uninterrupted ring.
- the ring shaped surface contacting the skin 3 can have interruptions such as, for example, recesses, which may, however, be small enough not to spoil the described function of the pressure ring 1 .
- the lancing system 10 can work without a z-position detection and without a penetration depth reference element adapted for contacting the skin 3 which can bulge into the pressure ring 1 .
- the starting point of the MITP can be a point in time at which the lancing system 10 may be “ready for lancing”, i.e., the lancing drive 14 may be ready for driving a lancing movement of a lancing element 12 connected thereto and the desired lancing site of the skin 3 may be properly located at the skin contact opening 4 of the instrument 11 .
- a short period of time may be required between establishing the status “ready for lancing” and the triggering of the puncturing movement.
- Such a short preparatory delay period may be required by the instrument 11 , for example for detecting the skin 3 position.
- no such preparatory time period may be needed due to instrumental requirements, i.e. the triggering can immediately take place when the status of the lancing system 10 is “ready for lancing.”
- the starting point of the MITP may coincide with the triggering of the puncturing movement.
- a very short, well defined preparatory delay period may, however, be provided for non-instrumental reasons; in particular, to take into account visco-elastic deformation of the skin 3 which may take place after establishing a pressure force between the skin 3 and the pressure ring 1 .
- sample collection device 36 can be any part of the lancing system 10 , inside the instrument 11 , in which body fluid sample produced as a result of skin lancing can be available for analysis. It can, for example, be a chamber or capillary and can be empty, or filled with bibulous material.
- the MITP can be a user-independent quantity which may depend only on the design of the lancing system 10 .
- the instrument 11 can comprise a MITP controlling device 17 .
- This term can refer to any device which can help ensure that the required interaction between the user and the instrument 11 , i.e., the required pressing force F between the skin 3 and the pressure ring 1 , is maintained by the user at least during the MITP.
- the MITP controlling device 17 can provide assistance to ensure that the actual interaction between the user and the instrument 11 overlaps, or at least coincides with, the MITP.
- the MITP controlling device 17 need not operate fully automatically in the sense that no acts of the user, such as manual triggering of the puncturing movement, may be required. Rather, it may provide assistance to the user, in particular, by signaling to the user directly or indirectly the start and the end of the MITP. In one embodiment, the end of the MITP period can generally be indicated to the user by a suitable visible, audible or tactile signal.
- the MITP controlling device 17 can comprise detecting the starting point of the MITP, by detecting the pressing force F acting between a pressure ring 1 and the skin 3 using any suitable methods known in the art.
- this status can be indicated to the user by a suitable visible, audible or tactile signal.
- the lancing movement can be triggered automatically when the status “ready for lancing” has been detected. In this case, there may be no delay between “ready to lance” and triggering, i.e., the MITP starts with the automatic triggering.
- there may be an instrument-controlled delay time e.g., to take into account the time needed for visco-elastic skin-deformation.
- the preparatory delay period between “ready to lance” and triggering can range between about 0.2 sec to at most about 1 sec. In another embodiment, the preparatory delay period can range between about 0.3 sec to at most about 0.7 sec. In yet another embodiment, the preparatory delay period can range between about 0.4 sec to at most about 0.5 sec.
- a dedicated MITP controlling device 17 may not be necessary. Depending on the particular situation, it may be sufficient for the user to be provided with an indirect indication of the start and end of the MITP. For example, the “ready to lance” status can be “felt” by the user when pressing his finger 2 on a spring-supported pressure ring 1 and the duration of the MITP may be so short, that it may by sufficient to rely on the “feeling” of the user with respect to the end of the MITP.
- the instrument 11 may have a fill control, as part of the MITP controlling device 17 , to indicate a sufficient amount of body fluid sample or to allow an analysis, only if a sufficient amount of sample has been collected.
- the fill control may not be required. Rather, the end of the MITP can be calculated by the instrument 11 using a fixed MITP value (depending on the design of the lancing system 10 components).
- the instrument 11 furthermore can comprise a pressure-ring-movement detection device 45 .
- the pressure-ring-movement detection device 45 can be part of a MITP controlling device 17 . Movement detection can be, for example, a light barrier. Such a device can detect the movement of a pressure piece 42 , and, hence, of the pressure ring 1 , upon pressing down from its “home” position by a finger 2 .
- Such detection can allow several favorable functions including an indication to the user, via display 16 or generators of audible or tactile signals 18 and 19 , that the instrument 11 is “ready for lancing.”
- the signal of the pressure-ring-movement detection device 45 can be used for automatically triggering the lancing movement, possibly after a delay time as described above.
- FIG. 3 furthermore shows an analysis measurement device 47 as part of the instrument 11 .
- This can be any device suitable to measure a value of a measurement quantity relating to a change of analysis element 21 , wherein change can be a measure of the desired analytical value.
- the analysis measurement device 47 can be for a photometric measurement of a detection area in the analysis zone 8 of analysis element 21 including a light source 48 , a light detector 49 and corresponding light guide means symbolized by a lens 50 .
- Other types of analysis measurement devices 47 can be used as well, such as, for example, electrical measurement devices for the evaluation of electrochemical analysis elements 21 .
- a MITP control device 17 can make use of the pressure-ring-movement detection device 45 .
- MITP control device 17 signals the start of an MITP, it can generate a signal by at least one of signal generator devices 18 and 19 and/or can automatically trigger a puncturing movement of lancet drive 14 .
- the end of the MITP period can be determined by the measurement and evaluation electronics 15 , for example, on the basis of a predefined time period required for generation and transfer of sufficient amount of body fluid sample from the finger tip 2 .
- the status of a sufficient sample transfer may be separately detected by suitable sample transfer detection as is known in the art, such as, for example, photometric detection of the sample transported in the integral lancing and analysis element 22 , or by electrical contacts detecting that body fluid sample transported therein has reached a certain point in its transport path.
- suitable sample transfer detection such as, for example, photometric detection of the sample transported in the integral lancing and analysis element 22 , or by electrical contacts detecting that body fluid sample transported therein has reached a certain point in its transport path.
- the application force control device can ensure that during the entire MITP, the pressing force F is within a given range.
- the variation of the pressing force F during the MITP may be within the identified variation limitations which can be much smaller.
- the present disclosure can use a simple and inexpensive design. For example, in order to adapt for small remaining variations of the skin 3 position, it may be sufficient to provide interchangeable distance elements or pressure rings 1 to allow a single adaption of the lancing systems 10 to the needs of a particular user.
- the instrument 11 and lancing system 10 can take into account the viscoelastic properties of the skin 3 in an optimized manner. In this way, not only a sufficient supply of body fluid sample can be ensured but also “flooding” by too much body fluid sample can be avoided. Reliable analysis can be possible even with very small sample volumes, e.g., less than about 300 nl, or even less than about 200 nl.
- the term “substantially” is utilized herein to represent the inherent degree of uncertainty that may be attributed to any quantitative comparison, value, measurement, or other representation.
- the term “substantially” is also utilized herein to represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue.
Abstract
Description
- This application is a continuation of PCT/2008/003355, filed Apr. 25, 2008, which is based on and claims priority to U.S. Provisional Application Ser. No. 60/914,897, filed Apr. 30, 2007, which are hereby incorporated by reference.
- The present disclosure generally relates to the collection of body fluid for analysis, i.e., the determination of an analyte concentration therein and, in particular, relates to instruments and systems for producing a small body fluid sample by piercing the skin of a subject (human or animal) using a disposable lancing element having a skin piercing tip suitable for generating a small wound from which the sample is drawn. Depending on the skin site used and on the lancing depth the body fluid is blood or interstitial fluid or a mixture thereof.
- Analysis based on skin-piercing can be important in several fields of medical diagnostics and treatment. Of particular importance is the field of diabetes management. It has been determined that severe long term damages caused by diabetes mellitus can be avoided if the patient controls her or his blood sugar level several times a day in order to adapt the required insulin injections closely to the actual need for maintaining a constant blood sugar level. This requires so called “home-monitoring” by the patient himself or by other people not having a medical training.
- Other important fields of medical diagnostics and treatment with similar requirements, including home-monitoring, refer, for example, to the regular control of blood cholesterol and to the control of blood coagulation parameters. The present disclosure may be particularly suitable, but not limited, to home-monitoring applications. Similar requirements may also exist, e.g., in so-called “near-patient-testing.”
- Lancing of the skin is generally performed by a lancing system comprising, as mutually adapted components of the system, a reusable hand-held instrument and lancing elements. The movement for lancing (i.e., puncturing movement) is driven by a lancing drive provided inside a housing of the instrument and adapted for driving a lancing element connected thereto. Lancets can be interchangeably connected to the drive and generally are disposable items.
- After triggering the puncturing movement, the lancet is driven in a puncture direction until it reaches a point of maximum displacement and thereafter it is further driven in a reverse direction. Many suitable lancet drive mechanisms have been described in the prior art. In most cases, the driving force is supplied by a tensioned spring and the lancet drive further includes suitable mechanical means for converting the force of the spring into the required movement of a lancet.
- An important consideration in developing lancing systems can be the pain caused by the pricking action. This pain and the convenience of use are typically decisive factors determining compliance of the patient, i.e., his or her willingness to perform regular analyses as required for maintaining his or her health. The reliable production of the required amount of body fluid sample with minimum pain highly depends on the reproducibility of an optimum penetration depth of the tip of the lancing element into the skin (see e.g., U.S. Pat. No. 5,318,584).
- With earlier lancet systems, the analysis generally required a plurality of steps to be performed by the user. After lancing with such earlier systems, the body fluid sample typically did not readily emanate from the wound site in the lanced skin. Therefore, manual “milking” steps such as pinching, squeezing and kneading where necessary in order to express the required amount of body fluid sample. Finally, the body fluid sample was contacted to an analysis element of an analysis system, which typically was separate and distinct from the lancing system, and the analysis was performed thereby.
- In order to improve the production of the body fluid sample at the lancing site and to avoid the manual “milking,” several proposals have been made all of which relate to the design of the contact area at a distal end of the lancing instrument having a generally ring-shaped skin contact surface surrounding a skin contact opening. Such lancing systems have been described in: WO 99/26539; WO 01/89383 A2; EP 1 245 187 A1; EP 1 586 269; and EP 1 586 270.
- While these approaches differ in several ways, a common feature is that the skin contact opening has a relatively large diameter whereby the skin bulges into the skin contact opening forming a target site bulge which penetrates to some extent into the opening when the lancing instrument is pressed with its distal end, i.e., with the skin contact surface, against the skin. This bulging action, hereafter designated “target site bulging,” is generally combined with additional methods for improving body fluid sample production, such as, for example, a mechanical squeezing acting radially inwardly, a pumping action involving axial movement of parts of the instrument, etc.
- Ideally, these measures allow with a high success rate, preferably greater than 90%, expression of a sufficient amount of body fluid sample without manual “milking.” This again may be a requirement of integrated lancing and analysis systems which, in a single instrument, typically comprises both a lancing-type sample production and a method of analysis. Such integrated systems have been proposed in a plurality of variants which can be assigned generally to two types, namely:
-
- A) “Two unit systems” comprising two separate units for lancing and for analysis in a single instrument housing. Typically, the units are moved one after the other to a common skin contact opening (see e.g., EP 1 669 028 A1 and EP 1 736 100 A1); or
- B) “Single unit systems” comprising a single combined lancing and analysis unit suitable for performing both functions: lancing and analysis. Most of such systems operate with both integrated lancing and analysis elements. The two components of such combined lancing and analysis elements are generally manufactured separately but assembled by the manufacturer, or at least before use, i.e., before the lancing movement is triggered. In the instrument, such elements are typically processed as a unified item. In other single unit systems, both functions, lancing and analysis, are performed by the same unit but a lancing element and an analysis element are provided and processed separately during at least part of the analytical procedure. Examples of single unit systems are described generally in: WO 01/72220; WO 03/009759 A1; EP 1 342 448 A1; EP 1 360 933 A1; and EP 1 362 551 A1.
- Typically, target site bulging occurs when a lancing instrument is pressed against the skin, or vice versa, at the lancing site. While this bulging is favorable regarding expression of a sufficient amount of body fluid sample, it may cause a problem regarding reproducibility of the penetration depth by which the tip of the lancing element penetrates into the skin. With a given adjustment of the longitudinal position, i.e., position in the direction of the lancing movement; hereafter “z-position,” of the lancing drive and consequently a given z-position of the point of maximum displacement of the lancet the penetration depth depends on the exact z-position of the skin surface during the puncturing movement. Due to the bulging of this skin, position is substantially undefined. It depends on a plurality of factors including, not only differing skin elasticity of different users, but also including changes of the elastic and other properties of the skin of a particular user caused by influencing factors such as, for example, temperature, previous skin treatment, e.g., washing with soap, and choice of the particular lancing site.
- Prior art approaches for overcoming this uncertainty about the skin position and the resulting uncertainty about the penetration depth include:
-
- (1) Detection of the exact z-position of the skin by a skin position detection device integrated into the lancing instrument and operating, for example, by electric (capacitive) or optical detection means (WO 03/088835), and
- (2) Providing in the instrument, a penetration depth reference element having a reference skin contact surface which is contacted to the skin (additionally to the skin contact surface surrounding the skin contact opening of the instrument), for providing a reliable z-position reference during penetration of the lancing element tip into the skin. Such a reference element can be moved towards the skin separately from the lancing element (see e.g., EP 1 669 028 A1) or together therewith (see e.g., WO 2006/092309).
- While these approaches may help to achieve a reproducible penetration depth, they still require a substantial expense in the instrument design and production, making the system less handy and more costly. Therefore, several of the lancing systems designed for target site bulging simply disregard the penetration depth uncertainty. This approach causes, however, a much more pain than necessary, because it requires a higher penetration depth setting to make sure that a sufficient amount of body fluid sample is produced even with a disadvantageous position of the lancing site bulge.
- According to the prior art, timing has generally been only a concern with respect to the “test time”, i.e., the total time required for the analysis from lancing until the analyte concentration is indicated. In contrast, according to the present disclosure, the duration of the minimum interaction time period (“MITP”) can be highly critical. This time period can be defined as the minimum time duration for which user-instrument interaction can be required for lancing and for collecting a sufficient amount of sample for the analysis in a sample collection device of the system. The functions performed during the MITP can include lancing, expression of body fluid sample from the tissue, preferably directly into a capillary of the lancing element, and collecting a sufficient amount of sample.
- The MITP can be a system-related quantity which can be user-independent, i.e., only determined by the design of the instrument, and possibly by other components of the system. It may not be confused with the actual time of interaction which in each case can depend on numerous aspects including the habits of the user. The actual interaction time generally can vary between users and, even for a specific user, from analysis to analysis. The present disclosure can design the system in such a manner, that the minimum time for which every user must at least interact with the instrument, can be below the indicated very small threshold values.
- Even though several of the discussed systems, in particular integrated lancing and analysis systems, provide improved results as compared to earlier known devices, they still posses substantial shortcomings. Therefore, there is a need for improvements to lancing and analysis systems that may include, for example, ease of use and minimum pain as well as minimum volume, weight and production costs.
- Furthermore, many users of integrated lancing and analysis systems have problems maintaining a sufficient pressing force for a sufficient period of time. Therefore, there is a need for a system that improves user compliance with recommended rules.
- According to the present disclosure, an instrument and a system for producing a sample of body fluid by piercing the skin is disclosed. The instrument and system can comprise a housing, a lancing drive within the housing adapted for being connected to a lancing element and adapted for driving a lancing element connected thereto in a puncturing movement in which the lancing element moves, after triggering the puncturing movement, in a puncture direction until it reaches a point of maximum displacement and in a reverse direction after it has reached the point of maximum displacement, and a pressure ring surrounding a skin contact opening and being adapted for being pressed against the skin such that the skin bulges into the opening whereby expression of body fluid is promoted after the piercing tip of a lancing element has pierced the skin. The skin contact opening can have an opening area corresponding to a circle with a diameter of at least about 3 mm and at most about 8 mm. The instrument can include a pressing force control device for controlling the force acting between the pressure ring and the skin (“pressing force”) at the time of triggering the puncturing movement, to be at least about 3 N and at most about 8 N.
- In accordance with one embodiment of the present disclosure, the system and an instrument for producing a sample of body fluid by piercing the skin can use a lancing element having a skin piercing tip and, for analysis, can use a disposable analysis element. The instrument can comprise a housing, a lancing drive within the housing adapted for being connected to a lancing element and adapted for driving a lancing element connected thereto in a puncturing movement in which the lancing element moves, after triggering the puncturing movement, in a puncture direction until it reaches a point of maximum displacement and in a reverse direction after it has reached the point of maximum displacement, a pressure ring surrounding a skin contact opening and being adapted for being pressed against the skin such that the skin bulges into the opening whereby expression of body fluid is promoted after the piercing tip of a lancing element has pierced the skin, and a holding device adapted for holding an analysis element in the housing such that a sample of body fluid produced by piercing the skin can be transported thereto for analysis. A minimum interaction time period required for lancing and sampling a sufficient amount of body fluid sample for analysis can be at most about 3 seconds. Preferably the minimum interaction time period can be no more than about 2 seconds and more preferably it can be no more than about 1 second.
- In accordance with another embodiment of the present disclosure, the user can interact with the system by establishing a pressing force between the skin and the pressure ring of the instrument by pressing the hand-held instrument against the finger or other body part. Alternatively, the finger or other body part can be pressed against the instrument by, for example, lying on a table.
- Accordingly, it is a feature of the embodiments of the present disclosure to provide lancing and analysis systems with improvements such as, for example, ease of use, minimum pain, user compliance, and minimum volume, weight and production costs. Other features of the embodiments of the present disclosure will be apparent in light of the description of the disclosure embodied herein.
- The following detailed description of specific embodiments of the present disclosure can be best understood when read in conjunction with the following drawings, where like structure is indicated with like reference numerals and in which:
-
FIG. 1 illustrates a schematic sketch relating to the principles of target site bulging according to an embodiment of the present disclosure. -
FIG. 2 illustrates a perspective view of an analysis instrument according to an embodiment of the present disclosure. -
FIG. 3 illustrates a longitudinal section of the instrument shown inFIG. 2 according to an embodiment of the present disclosure. -
FIG. 4 illustrates a perspective view of a lancing element for use in the instrument shown inFIG. 3 according to an embodiment of the present disclosure. -
FIG. 5 illustrates a schematic sketch regarding an aspect of the function of the instrument shown inFIG. 3 according to an embodiment of the present disclosure. - In the following detailed description of the embodiments, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration, and not by way of limitation, specific embodiments in which the disclosure may be practiced. It is to be understood that other embodiments may be utilized and that logical, mechanical and electrical changes may be made without departing from the spirit and scope of the present disclosure.
- Referring initially to
FIGS. 1-3 ,FIG. 1 illustrates symbolically the point P of maximum displacement which a piercingtip 7 reaches on its movement path during the puncturing movement. In one embodiment, a “two unit system,” thesample collection device 36 can belong to the analysis unit. It can be a part of ananalysis element 21, or of a dedicated sample collection element, and can collect body fluid sample after the analysis unit has been moved to the skin contact opening 4. In another embodiment, a “single unit system,” thesample collection device 36 can be a part of a lance element, a part of ananalysis element 21, a part of an integrated lancing andanalysis element 22 or a part of a dedicated sample collection element. - If the
sample collection device 36 is a part of ananalysis element 21, or of an integrated lancing andanalysis element 22, it can, in particular, be a part of a reaction zone thereof containing reagents which react with the body fluid sample, thereby producing some kind of measurable physical change which can be characteristic for the analysis. - In one exemplary embodiment, the
sample collection device 36 can be separate from the reaction zone of theanalysis element 21 and can include a reservoir, which can be suitable for storing a body fluid sample for an intermediate storage time which may be longer than the minimum interaction time period (“MITP”). One advantage of this embodiment can be that it can allow to separate the timing requirements of the sample collection from the timing requirements of the analysis. The MITP can be terminated as soon as the reservoir of thesample collection device 36 contains a sufficient amount of body fluid sample for the analysis. Further steps, including, for example, the filling of a reaction zone, can take place separately without continued interaction of the user. The transfer of the body fluid sample from the reservoir of thesample collection device 36 to the reaction zone of theanalysis element 21 can either take place spontaneously or with controlled timing. In the former case, permanent fluid communication can be provided between the reservoir and the reaction zone. In the latter case, the fluid communication from the reservoir of thesample collection device 36 to theanalysis element 21 can be “switchable,” i.e., initially, preferably at least for the duration of the MITP, there may be no fluid communication but same may be established in a controlled manner at a suitable point of time. Suitable methods for such switching are well known in the art. - Returning to
FIG. 1 , a pressure ring 1 against which a finger tip 2, or any other suitable body part, can be pressed with a pressing force F. Due to this pressing force F, the skin 3 may bulge into a skin contact opening 4 which can be defined by the pressure ring 1, forming a target site bulge 6. Withmost lancing instruments 11, the z-positions of the plane of the pressure ring 1 and the point of maximum displacement P relative to each other, shown as distance sFIG. 1 , can be adjusted in order to allow a penetration depth setting.FIG. 1 illustrates, that for a given value of this adjustment, the actual penetration depth x can depend directly on the distance d, i.e., the degree of target site bulging 6. - The degree of target site bulging 6, i.e., the distance d between the plane of pressure ring 1 and the apex of target site bulge 6, can be influenced by many factors such as, for example, the size of the skin contact opening 4, the pressing force F and the viscoelastic properties of the skin 3. These factors can further depend on a plurality of other aspects including, for example: (1) the elasticity of the skin 3 surface of the particular individual which largely differs depending on age, sex and degree of manual work generally performed by the particular person; (2) the internal pressure in the finger 2, or other body part, which depends among others on the health status and the physical activity of the particular person; (3) ambient conditions, including in particular temperature and humidity, influencing the viscoelastic properties of the skin 3; and (4) skin 3 treatment preceding the lancing, such as washing with soap, disinfecting etc.
- Generally, the skin contact opening 4 can be substantially circular. In one embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 3 mm to about 8 mm. In another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 4 mm to about 7 mm. In yet another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 5 mm to about 6.5 mm. In still another embodiment, the skin contact opening 4 can have an inner, free diameter in the range of at least about 5.5 mm to about 6 mm. In the case of a non-circular skin contact opening 4, the area of the skin contact opening 4 can substantially correspond, i.e., be about the same, as the area of a circle with the above mentioned diameter values. However, in one embodiment, the smallest inner, free width of a non-circular skin contact opening 4 can be at least about 3 mm. In another embodiment, the smallest inner, free width of a non-circular skin contact opening 4 can be at least about 4 mm.
- As noted above, in the prior art, the uncertainty about the actual z-position of the skin 3, i.e., the apex of the target site bulge 6, has either been disregarded or has been taken into account by measuring or referencing the actual skin 3 position. In contrast, the present disclosure has surprisingly found that a very good reproducibility of the penetration depth during lancing can be achieved if the specified conditions concerning the area of the skin contact opening 4 and the amount of the pressing force F are maintained.
-
FIGS. 2-5 illustrate anexemplary lancing system 10. The lancingsystem 10 can include a reusable hand-heldinstrument 11 and a disposable lancingelement 12 with a piercingtip 7. Ahousing 13 of theinstrument 11 can contain a lancingdrive 14 and a measurement andevaluation electronics 15, shown symbolically inFIG. 3 . Adisplay 16 can be provided to the user in order to allow visual indication of information including, for example, status information concerning the lancingsystem 10, advice concerning its handling, analytical results and any other suitable information. Optionally, theinstrument 11 also can comprise a MITP controlling device 17, adevice 18 for generating audible signals such as, for example, a buzzer, and/or adevice 19 for generating tactile signals such as, for example, a vibration generator. - In one exemplary embodiment, best shown in
FIG. 4 , a lancingelement 12 can be combined with ananalysis element 21 to form an integral lancing andanalysis element 22. In theintegral element 22, the lancingelement 12 can be movable in a longitudinal direction symbolized by thedouble arrow 34. Ananalysis element holder 20 can be provided for holding theanalysis element 21 inside theinstrument 11. In one exemplary embodiment, theanalysis element holder 20 can comprise acoupling recess 25 in theanalysis element 21 and acorresponding coupling protrusion 27 of theinstrument 11. In a similar manner, the lancingelement 12 can have acoupling recess 24 cooperating with acoupling protrusion 26 of theinstrument 11. These pairs ofrecesses protrusions analysis element 22 which can be inserted into theinstrument 11, as seen inFIG. 3 . - In one embodiment, the
lancet drive 14, shown inFIG. 3 , can comprises adrive rotor 29 with acam 30 formed by a groove. Thecam 30 and acorresponding cam traveler 31 can form a cam drive mechanism which can control a pivoting movement of adrive rod 32 about a pivotingaxis 33. - After triggering of a puncture movement, by a triggering method, the
drive rotor 29 can turn with high speed, driven by a drive spring, about itsaxis 35. This rotational movement can be translated by a cam curve formed bygroove 30 and traveled bycam traveler 31 into a corresponding pivoting movement ofdrive rod 32 which again can drive a corresponding up and down movement of lancingelement 12 to which it can be connected by itscoupling protrusion 26 penetrating intocoupling recess 24.Similar drive rotor 29 for lancinginstruments 11 are known in the art, therefore, no more detailed description may be necessary. - In the exemplary embodiment shown in
FIG. 4 , the lancingelement 12 can be a “direct sampler” having acapillary channel 28 inside its piercingtip 7 and leading up to asample collection zone 23 of lancingelement 12. Insample collection zone 23, thecapillary channel 28 can widen to form asample reservoir chamber 28 a. - During lancing, the lancing
element 12 can perform a puncturing movement by which piercingtip 7 can be driven into skin 3. Thereafter, during a retraction phase of the puncturing movement, after the piercingtip 7 has reached its point of maximum displacement P but with the piercingtip 7 still below the surface of skin 3, a body fluid sample can penetrate, driven by capillary forces, into thecapillary channel 28 andreservoir chamber 28 a. Thus, the capillary 28 andreservoir chamber 28 a together can form asample collection device 36 suitable for storing body fluid sample, ready for subsequent transfer to an analysis zone 8 ofanalysis element 21. - Once the body fluid sample arrives at
sample collection zone 23, it may be transferred to the adjacent analysis zone 8 ofanalysis element 21 by a suitable fluid communication device. In one embodiment, the arrangement can be such that there can beno fluid communication between thesample collection zone 23 of lancingelement 12 and theanalysis element 21. In a second embodiment, fluid communication can take place. The switching between the two embodiments can be accomplished by any suitable method known in the art such as, for example, by pressingsample collection zone 23 of lancingelement 12 andanalysis element 21 together. - Alternatively, the present disclosure can also be used with integral lancing and
analysis elements 22 having a lancing part and an analysis part fixed together. In this embodiment, two separate holding devices may not be required. Instead, one holding device may be provided which simultaneously serves as lancingelement 12 holding device and as analysis element holding device. - While devices for holding and moving a lancing
element 12 and ananalysis element 21, or an integral lancing andanalysis element 22, in theinstrument 11 have been described, many other suitable devices can be possible. Such devices can include, for example, a design in whichanalysis elements 21 and/or lancingelements 12 can be fixed to and transported by means of a tape during at least a part of the lancingsystem 10 operation. - In one embodiment, the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 3 N to about 8 N. In another embodiment, the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 4 N to about 7 N. In yet another embodiment, the pressing force F acting at the time of triggering the puncturing movement between the pressure ring 1 and the skin 3 can be in the range of at least be about 5 N to about 6 N. A defined pressing force F within these limits can be ensured by a suitable pressing
force control device 37. The limiting values of the pressure force can be with respect to the requirements of withdrawing sample from the skin 3. - However, this does not mean that the pressing force F can be allowed to float in that range during the MITP. Rather, in one exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 15%. In another exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 10%. In yet another exemplary embodiment, the maximum variation range of the pressing force F can be limited to no more than about 5%. Expressed in absolute values, in one exemplary embodiment, the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/−0.5 N. In another exemplary embodiment, the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/−0.3 N and, in yet another exemplary embodiment, the maximum variation range of the pressing force F between the pressure ring 1 and the skin 3 during the MITP may be no more than about +/−0.2 N.
- In one exemplary embodiment, the pressing
force control device 37 can be mechanical, in particular, it can comprise aspring device 38 which can be arranged in such a manner that its spring force can act between the pressure ring 1 and thehousing 13. In one embodiment, thespring device 38 can be a metal spring. Other suitable spring-like devices are, however, known in the art and can be used, such as, for example, a pneumatic spring or a resilient element of an elastic material. Hereafter, the term “spring” can be used as an example of anysuch spring device 38. In one exemplary embodiment, thespring device 38 can be pre-tensioned. - In one exemplary embodiment, pressing
force control devices 37 operating by electrical methods may comprise an electromagnetic drive including a coil and a magnetic core, in particular a voice coil drive. The control of the pressure can be fully automatic or it can require an activity of the user. In the latter case, electrical methods can be used to measure the force by which the pressure ring 1 may be pressed against the skin 3 and this force can be indicated to the user by suitable visible, acoustic or tactile methods, whereby the user can adapt the pressing force F to the desired value. - A special feature according to one embodiment of the present disclosure can relate to a pressing
force control device 37 provided in theinstrument 11. In this embodiment, the pressingforce control device 37 can comprise aspring 38 which can be embodied and arranged in such a manner that one end thereof can act against pressure ring 1 and the other end can act against thehousing 13. The term “acting” in this context may not require immediate contact. Instead, it can mean that the spring can exert a force on the pressure ring 1 and that the corresponding counter-force can be, directly or indirectly, borne by thehousing 13. - In one embodiment, the
instrument 11, shown inFIG. 3 , can comprise one end ofspring 38 that can rest on a wall ofhousing 13 and another end that can press against aframe element 39 carrying lancingdrive 14. The force ofspring 38 can be further transmitted from theframe element 39 to pressure ring 1 viapillar elements 40. Pressure ring 1 can be embodied as part of apressure piece 42 which can be borne by a pressure ring bearing 43 ofhousing 13 such that it can be axially movable against the force ofspring 38. - In one exemplary embodiment, when a user presses her or his finger tip 2 in the direction of arrow F onto
pressure piece 42 with pressure ring 1, the latter can move downwardly against the force ofspring 38, orother spring device 38 known in the art. As soon as the contact betweenpressure piece 42 and thehousing 13 at pressure ring bearing 43 is interrupted, the force ofspring 38 can be balanced by the pressing-down force of the finger 2. In other words, the force by which the pressure ring 1 may be pressed against the skin 3 can be in this status controlled by the pressingforce control device 37, such as, for example, by aspring 38. -
FIG. 5 illustrates that thespring 38 can act betweenhousing 13 andpressure piece 42 with pressure ring 1. The lancingdrive 14 can be connected in a defined spatial configuration with pressure ring 1, in such a manner that the distance between the point of maximum displacement P of the lancet movement and the pressure ring 1 can be independent from the compression status of thespring 38 and the corresponding axial movement ofpressure piece 42. In one exemplary embodiment, the spatial configuration and, hence, the distance of the pressure ring 1 from the point of maximum displacement P can be varied, between puncturing movements, to set the lancing penetration depth. However, it can be fixed during the interaction of the user with the device, i.e., from the point of time at which the pressure ring 1 can be first pressed down until the body part 2 is removed therefrom. - The
elastic spring 38 can increase linearly with its elongation, i.e., compression in the case of a compression spring as shown. In one exemplary embodiment, the pressure ring 1 pressed against the skin 3 can be controlled closely, i.e., the variation thereof may not exceed the preferred limiting values. In this exemplary embodiment, thespring 38 can be arranged in such a manner that it may be pre-tensioned. This means that the spring can already be compressed, or in the case of an extension spring can be extended, even if no pressing force F is exerted onto pressure ring 1, i.e., the pressure ring 1 is in its “home” position resting on the surrounding wall, bearing 43, ofhousing 13. In one exemplary embodiment, the degree of this pre-tensioning can be such that the force ofspring 38 acting on the pressure ring 1 can vary by no more than about 20% within the spring-loaded movement range of the pressure ring 1. In another exemplary embodiment, the force ofspring 38 acting on the pressure ring 1 can vary by no more than about 10%. - In this context, it may be important to make sure, that in the entire movement range, the pressing-force acting between the finger 2, or other body part, and the pressure ring 1 can be controlled only by the force of
spring 38 balanced by the pressing-down-force of finger 2. This condition may not be met if the movement of pressure ring 1 was influenced or limited by some kind of abutting member or obstacle acting, within its possible movement range, on ring 1. In order to meet this condition, a pressure ring movement limiting arrangement 44 (seeFIG. 5 ) can be provided by which the maximum displacement P of the pressure ring 1 possible by pressing with a finger 2, or other body part, can be limited within a fully spring-loaded movement range of the pressure ring 1. - In one exemplary embodiment, shown in
FIG. 5 , this can be achieved by acontact surface 46 which can be arranged in the vicinity, at the outer side, of the pressure ring 1 in such a manner that a body part pressed against the pressure ring 1, and thereby moving the pressure ring 1, can abut against thecontact surface 46. Due to this abutting, the pressure ring 1 cannot be moved further, i.e., the possible displacement of the pressure ring 1, by the body part 2 pressing thereagainst, can be limited. In this embodiment, the maximum displacement P can depend on the distance dr by which the pressure ring 1 can protrude from theinstrument housing 13,contact surface 46. Whenpressure piece 42 with pressure ring 1 is pressed downwardly, this movement can be discontinued when finger tip 2 contacts the surface ofhousing 13 in the vicinity of the pressure ring 1. - It may be favorable for the maximum displacement P of the pressure ring 1 during practical use to be small. In one embodiment, it can be less than about 3 mm. In another embodiment, it can be less than about 2 mm. In still another embodiment, it can be less than about 1 mm. Therefore, the distance dr of the plane of pressure ring 1 and the
adjacent housing 13 surface, may not be too large. In one exemplary embodiment, maximum values can be calculated by adding approximately 0.5 mm to the mentioned maximum displacement P values. - On the other hand, dr may not be too small because a protrusion of the pressure ring 1 versus the
adjacent housing 13 area can simplify the finding of a suitable finger 2 position for the user. Therefore, in one embodiment, this protrusion, i.e., the distance, dr, can be at least about 0.2 mm. In another embodiment, the distance, dr, can be at least about 0.5 mm. - In one exemplary embodiment, the pressure ring 1 may be non-deformable in the sense that it may not be visibly deformed during normal use of the lancing
system 10. A suitable exact shape and width of the pressure ring 1 can be determined experimentally. In one embodiment, the pressure ring 1 can have a width of at most about 3.5 mm. In another embodiment, the pressure ring 1 can have a width of at most about 2.5 mm. In yet another embodiment, the pressure ring 1 can have a width of at most about 1 mm. In one embodiment, the pressure ring 1 can have a minimum width of about 0.5 mm. In another embodiment, the pressure ring 1 can have a minimum width of about 0.7 mm. In yet another embodiment, the pressure ring 1 can have a minimum width of about 0.8 mm. The pressure ring 1 may protrude from anyadjacent housing 13 surface by a sufficient distance to allow easy tactile recognition thereof by the user. - Of course, the pressure ring 1 can have many different shapes and designs as known in the art. The term “pressure ring” can refer to the ring-shaped surface of the respective part which in practical use, i.e. under the conditions prevailing in using of the
particular instrument 11, can contact the skin 3 surface. Of course, this ring-shaped contact surface (i.e., the pressure ring 1) can have varying shapes including, for example, slightly rounded edges. - Furthermore, the term “pressure ring” may not be being limited to an uninterrupted ring. Instead, the ring shaped surface contacting the skin 3 can have interruptions such as, for example, recesses, which may, however, be small enough not to spoil the described function of the pressure ring 1.
- Excellent reproducibility of the z-position of the skin bulge 6 at the lancing site and, thus, an excellent reproducibility of the penetration depth can be achieved if particular conditions are ensured concerning the size of the skin contact opening 4 and concerning the force by which the pressure ring 1 and the skin 3 can be pressed against each other at the time of triggering the puncturing movement. This can allow target site bulging and automatic sample generation, without “milking,” combined with a simple and inexpensive design of the lancing
system 10. The lancingsystem 10 can work without a z-position detection and without a penetration depth reference element adapted for contacting the skin 3 which can bulge into the pressure ring 1. - The starting point of the MITP can be a point in time at which the lancing
system 10 may be “ready for lancing”, i.e., the lancingdrive 14 may be ready for driving a lancing movement of a lancingelement 12 connected thereto and the desired lancing site of the skin 3 may be properly located at the skin contact opening 4 of theinstrument 11. Depending on the design of the lancingsystem 10, a short period of time may be required between establishing the status “ready for lancing” and the triggering of the puncturing movement. Such a short preparatory delay period may be required by theinstrument 11, for example for detecting the skin 3 position. However, in one embodiment, no such preparatory time period may be needed due to instrumental requirements, i.e. the triggering can immediately take place when the status of the lancingsystem 10 is “ready for lancing.” In this embodiment, the starting point of the MITP may coincide with the triggering of the puncturing movement. - However, a very short, well defined preparatory delay period may, however, be provided for non-instrumental reasons; in particular, to take into account visco-elastic deformation of the skin 3 which may take place after establishing a pressure force between the skin 3 and the pressure ring 1.
- The end of the MITP may be marked by the fact that a sufficient amount of body fluid has been sampled, i.e., may be available in the
sample collection device 36 of theinstrument 11 for analysis. A “sample collection device” 36 as used herein can be any part of the lancingsystem 10, inside theinstrument 11, in which body fluid sample produced as a result of skin lancing can be available for analysis. It can, for example, be a chamber or capillary and can be empty, or filled with bibulous material. - In one embodiment, the MITP can be a user-independent quantity which may depend only on the design of the lancing
system 10. However, in another embodiment, theinstrument 11 can comprise a MITP controlling device 17. This term can refer to any device which can help ensure that the required interaction between the user and theinstrument 11, i.e., the required pressing force F between the skin 3 and the pressure ring 1, is maintained by the user at least during the MITP. In other words, the MITP controlling device 17 can provide assistance to ensure that the actual interaction between the user and theinstrument 11 overlaps, or at least coincides with, the MITP. - The MITP controlling device 17 need not operate fully automatically in the sense that no acts of the user, such as manual triggering of the puncturing movement, may be required. Rather, it may provide assistance to the user, in particular, by signaling to the user directly or indirectly the start and the end of the MITP. In one embodiment, the end of the MITP period can generally be indicated to the user by a suitable visible, audible or tactile signal.
- The MITP controlling device 17 can comprise detecting the starting point of the MITP, by detecting the pressing force F acting between a pressure ring 1 and the skin 3 using any suitable methods known in the art. In one embodiment, when the pressure corresponds to a predetermined minimum value or range, this status can be indicated to the user by a suitable visible, audible or tactile signal. Alternatively, the lancing movement can be triggered automatically when the status “ready for lancing” has been detected. In this case, there may be no delay between “ready to lance” and triggering, i.e., the MITP starts with the automatic triggering. Alternatively, there may be an instrument-controlled delay time, e.g., to take into account the time needed for visco-elastic skin-deformation. In one embodiment, the preparatory delay period between “ready to lance” and triggering can range between about 0.2 sec to at most about 1 sec. In another embodiment, the preparatory delay period can range between about 0.3 sec to at most about 0.7 sec. In yet another embodiment, the preparatory delay period can range between about 0.4 sec to at most about 0.5 sec.
- However, a dedicated MITP controlling device 17 may not be necessary. Depending on the particular situation, it may be sufficient for the user to be provided with an indirect indication of the start and end of the MITP. For example, the “ready to lance” status can be “felt” by the user when pressing his finger 2 on a spring-supported pressure ring 1 and the duration of the MITP may be so short, that it may by sufficient to rely on the “feeling” of the user with respect to the end of the MITP.
- In one embodiment, the
instrument 11 may have a fill control, as part of the MITP controlling device 17, to indicate a sufficient amount of body fluid sample or to allow an analysis, only if a sufficient amount of sample has been collected. However, the fill control may not be required. Rather, the end of the MITP can be calculated by theinstrument 11 using a fixed MITP value (depending on the design of the lancingsystem 10 components). - Advantages can be achieved with integrated lancing and
analysis systems 10 if the pressing force F between the pressure ring 1 at the distal end of the lancinginstrument 11 and the skin 3 is maintained, not only at the time of lancing, but, also, for a short interaction period thereafter: (1) With both types of integrated lancing andanalysis systems 10, maintaining this pressing force F for a MITP can help to produce a sufficiently large volume of body fluid sample; (2) In the case of two unit system, maintaining a MITP with the described pressing force F can furthermore be important to make sure that the position of theinstrument 11, i.e., its skin contact opening 4, relative to the skin 3 can be fixed until the point of time that the analysis device can be moved to the skin contact opening 4; and (3) With single unit system, maintaining a MITP with the described pressing force F can be important in order to allow a precise z-position of the lancing tip, thereby improving suctioning of a sufficient amount of body fluid sample during a short period of time. - In one exemplary embodiment, shown in
FIG. 3 , theinstrument 11 furthermore can comprise a pressure-ring-movement detection device 45. In one embodiment, the pressure-ring-movement detection device 45 can be part of a MITP controlling device 17. Movement detection can be, for example, a light barrier. Such a device can detect the movement of apressure piece 42, and, hence, of the pressure ring 1, upon pressing down from its “home” position by a finger 2. Such detection can allow several favorable functions including an indication to the user, viadisplay 16 or generators of audible ortactile signals instrument 11 is “ready for lancing.” Alternatively, or additionally, the signal of the pressure-ring-movement detection device 45 can be used for automatically triggering the lancing movement, possibly after a delay time as described above. -
FIG. 3 furthermore shows an analysis measurement device 47 as part of theinstrument 11. This can be any device suitable to measure a value of a measurement quantity relating to a change ofanalysis element 21, wherein change can be a measure of the desired analytical value. In one embodiment, the analysis measurement device 47 can be for a photometric measurement of a detection area in the analysis zone 8 ofanalysis element 21 including alight source 48, alight detector 49 and corresponding light guide means symbolized by alens 50. Other types of analysis measurement devices 47 can be used as well, such as, for example, electrical measurement devices for the evaluation ofelectrochemical analysis elements 21. - In the lancing
system 10 illustrated inFIGS. 2 to 5 , a MITP control device 17 can make use of the pressure-ring-movement detection device 45. Once MITP control device 17 signals the start of an MITP, it can generate a signal by at least one ofsignal generator devices lancet drive 14. The end of the MITP period can be determined by the measurement andevaluation electronics 15, for example, on the basis of a predefined time period required for generation and transfer of sufficient amount of body fluid sample from the finger tip 2. Alternatively, the status of a sufficient sample transfer may be separately detected by suitable sample transfer detection as is known in the art, such as, for example, photometric detection of the sample transported in the integral lancing andanalysis element 22, or by electrical contacts detecting that body fluid sample transported therein has reached a certain point in its transport path. The application force control device can ensure that during the entire MITP, the pressing force F is within a given range. The variation of the pressing force F during the MITP may be within the identified variation limitations which can be much smaller. - It has been found, that with suitable adaption of the minimum pressing force F and, also, of the upper limit of the pressing force F, and the maximum variation range, advantageously combined with a size of the skin contact opening 4, it can be even possible to design an
instrument 11 with no user-setable penetration depth adjustment. Surprisingly, with a single factory-set z-position of thelancet drive 14, point of maximal displacement, and of the pressure ring 1, relative to each other, a reliable production of body fluid sample can be possible with very little pain. Simultaneously, omission of a penetration depth adjustment device can allow a simple, compact and inexpensive design of theinstrument 11. - Even if a user-setable penetration depth adjustment device is provided, the present disclosure can use a simple and inexpensive design. For example, in order to adapt for small remaining variations of the skin 3 position, it may be sufficient to provide interchangeable distance elements or pressure rings 1 to allow a single adaption of the lancing
systems 10 to the needs of a particular user. - In general, the
instrument 11 and lancingsystem 10 can take into account the viscoelastic properties of the skin 3 in an optimized manner. In this way, not only a sufficient supply of body fluid sample can be ensured but also “flooding” by too much body fluid sample can be avoided. Reliable analysis can be possible even with very small sample volumes, e.g., less than about 300 nl, or even less than about 200 nl. - It is noted that terms like “preferably,” “commonly,” and “typically” are not utilized herein to limit the scope of the claimed embodiments or to imply that certain features are critical, essential, or even important to the structure or function of the claimed embodiments. Rather, these terms are merely intended to highlight alternative or additional features that may or may not be utilized in a particular embodiment of the present disclosure.
- For the purposes of describing and defining the present disclosure, it is noted that the term “substantially” is utilized herein to represent the inherent degree of uncertainty that may be attributed to any quantitative comparison, value, measurement, or other representation. The term “substantially” is also utilized herein to represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue.
- Having described the present disclosure in detail and by reference to specific embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the disclosure defined in the appended claims. More specifically, although some aspects of the present disclosure are identified herein as preferred or particularly advantageous, it is contemplated that the present disclosure is not necessarily limited to these preferred aspects of the disclosure.
Claims (42)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/582,277 US20110092854A1 (en) | 2009-10-20 | 2009-10-20 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
US13/873,046 US9186104B2 (en) | 2007-04-30 | 2013-04-29 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/582,277 US20110092854A1 (en) | 2009-10-20 | 2009-10-20 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/003355 Continuation WO2008131920A2 (en) | 2007-04-30 | 2008-04-25 | Instrument and system for producing a sample of a body liquid and for analysis thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/873,046 Continuation US9186104B2 (en) | 2007-04-30 | 2013-04-29 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110092854A1 true US20110092854A1 (en) | 2011-04-21 |
Family
ID=43879844
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/582,277 Abandoned US20110092854A1 (en) | 2007-04-30 | 2009-10-20 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
US13/873,046 Expired - Fee Related US9186104B2 (en) | 2007-04-30 | 2013-04-29 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/873,046 Expired - Fee Related US9186104B2 (en) | 2007-04-30 | 2013-04-29 | Instruments and system for producing a sample of a body fluid and for analysis thereof |
Country Status (1)
Country | Link |
---|---|
US (2) | US20110092854A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015530149A (en) * | 2012-08-27 | 2015-10-15 | ファセット テクノロジーズ エルエルシーFacet Technologies, LLC | Twist loading mechanism of puncture device |
US20180125400A1 (en) * | 2016-11-04 | 2018-05-10 | Apex Biotechnology Corp. | Glucose measuring device and apparatus |
CN112515669A (en) * | 2020-11-24 | 2021-03-19 | 为康(苏州)基因科技有限公司 | Gene detection quick sampling device |
US11399755B2 (en) | 2016-08-24 | 2022-08-02 | Becton, Dickinson And Company | Device for obtaining a blood sample |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
CA2725264C (en) | 2008-05-30 | 2017-06-20 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
WO2011065981A1 (en) | 2009-11-30 | 2011-06-03 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
JP6223337B2 (en) | 2011-08-03 | 2017-11-08 | インテュイティ メディカル インコーポレイテッド | Body fluid extraction measuring instrument |
CN109982628B (en) * | 2016-12-08 | 2023-09-08 | 英特尔公司 | Wearable assay systems and methods of use |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32922E (en) * | 1983-01-13 | 1989-05-16 | Paul D. Levin | Blood sampling instrument |
US5318584A (en) * | 1992-04-13 | 1994-06-07 | Boehringer Mannheim Gmbh | Blood lancet device for withdrawing blood for diagnostic purposes |
US6332871B1 (en) * | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US6561989B2 (en) * | 2000-07-10 | 2003-05-13 | Bayer Healthcare, Llc | Thin lance and test sensor having same |
US6589260B1 (en) * | 2000-05-26 | 2003-07-08 | Roche Diagnostics Corporation | System for withdrawing body fluid |
US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US20030191415A1 (en) * | 2001-03-29 | 2003-10-09 | Piet Moerman | Integrated sample testing meter |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US6749618B2 (en) * | 1999-10-19 | 2004-06-15 | Therasense, Inc. | Lancing device and method of sample collection |
US20040138588A1 (en) * | 2002-11-06 | 2004-07-15 | Saikley Charles R | Automatic biological analyte testing meter with integrated lancing device and methods of use |
US20040215224A1 (en) * | 2001-07-19 | 2004-10-28 | Tetsuya Sakata | Piercing device |
US20050011759A1 (en) * | 2000-03-02 | 2005-01-20 | Moerman Piet H. C. | Combined lancet and electrochemical analyte-testing apparatus |
US20050177071A1 (en) * | 2002-09-05 | 2005-08-11 | Hiroshi Nakayama | Invasive appliance |
US20060036187A1 (en) * | 2004-06-30 | 2006-02-16 | Hester Vos | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US20060155317A1 (en) * | 2004-12-10 | 2006-07-13 | Hans List | Lancet device for generating a puncture wound, and lancet drive assembly |
US20070004990A1 (en) * | 2005-06-23 | 2007-01-04 | Michael Kistner | Hand-held instrument for the analysis of body fluids |
US20070016103A1 (en) * | 2004-03-06 | 2007-01-18 | Irio Calasso | Body fluid sampling device |
US20070060842A1 (en) * | 2005-08-29 | 2007-03-15 | Manuel Alvarez-Icaza | Lancing cap kit applied pressure sensing cap |
US20070293882A1 (en) * | 2004-12-02 | 2007-12-20 | Herbert Harttig | Pricking device for taking blood |
US20080262387A1 (en) * | 2005-10-08 | 2008-10-23 | Hans List | Puncturing system |
US20090192409A1 (en) * | 2008-01-28 | 2009-07-30 | Daniel Wong | Rapid blood expression and sampling |
US20090275860A1 (en) * | 2005-03-31 | 2009-11-05 | Terumo Kabushiki Kaisha | Centesis Instrument |
US7955271B2 (en) * | 2006-10-13 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
US20110270129A1 (en) * | 2008-10-29 | 2011-11-03 | Roche Diagnostics Operations, Inc. | Instrument and system for producing a sample of a body liquid and for analysis thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU1827169C (en) | 1990-08-13 | 1993-07-15 | П.А.Хачик н | Device for piercing of epiderma |
GB9207120D0 (en) | 1992-04-01 | 1992-05-13 | Owen Mumford Ltd | Improvements relating to blood sampling devices |
US5964718A (en) | 1997-11-21 | 1999-10-12 | Mercury Diagnostics, Inc. | Body fluid sampling device |
US6306152B1 (en) | 1999-03-08 | 2001-10-23 | Agilent Technologies, Inc. | Lancet device with skin movement control and ballistic preload |
US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
JP2002219115A (en) | 2001-01-26 | 2002-08-06 | Matsushita Electric Works Ltd | Blood collecting device |
US6752817B2 (en) | 2001-03-26 | 2004-06-22 | Bayer Corporation | Split pressure ring for lancing device and method of operation |
DE10134650B4 (en) | 2001-07-20 | 2009-12-03 | Roche Diagnostics Gmbh | System for taking small amounts of body fluid |
US20030171696A1 (en) | 2002-03-05 | 2003-09-11 | Bayer Healthcare, Llc | Minimum invasive optical format with integrated lance |
WO2003088835A2 (en) | 2002-04-19 | 2003-10-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7303726B2 (en) | 2002-05-09 | 2007-12-04 | Lifescan, Inc. | Minimal procedure analyte test system |
JP2006512111A (en) | 2002-10-30 | 2006-04-13 | ライフスキャン・インコーポレイテッド | How to lance the skin for blood extraction |
US20060184189A1 (en) | 2002-11-15 | 2006-08-17 | Lorin Olson | Cap for a dermal tissue lancing device |
DE10332283A1 (en) | 2003-07-16 | 2005-02-03 | Roche Diagnostics Gmbh | System for taking body fluid |
US20050096686A1 (en) | 2003-10-31 | 2005-05-05 | Allen John J. | Lancing device with trigger mechanism for penetration depth control |
DK1722670T3 (en) | 2004-03-06 | 2014-01-06 | Hoffmann La Roche | Body fluid sampling device |
US20050234488A1 (en) | 2004-04-16 | 2005-10-20 | John Allen | Saddle-contoured cap for a dermal tissue lancing device |
US20050234491A1 (en) | 2004-04-16 | 2005-10-20 | Allen John J | Method for lancing a dermal tissue target site employing a dermal tissue lancing device with a tiltable cap |
EP1835848A4 (en) | 2004-12-30 | 2009-07-29 | Pelikan Technologies Inc | Method and apparatus for analyte measurement test time |
CA2598770C (en) | 2005-03-03 | 2011-07-19 | Frank Deck | Puncturing system for withdrawing a body fluid |
JP2007029417A (en) | 2005-07-27 | 2007-02-08 | Matsushita Electric Ind Co Ltd | Lancet |
US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
US20080065130A1 (en) | 2006-08-22 | 2008-03-13 | Paul Patel | Elastomeric toroidal ring for blood expression |
-
2009
- 2009-10-20 US US12/582,277 patent/US20110092854A1/en not_active Abandoned
-
2013
- 2013-04-29 US US13/873,046 patent/US9186104B2/en not_active Expired - Fee Related
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32922E (en) * | 1983-01-13 | 1989-05-16 | Paul D. Levin | Blood sampling instrument |
US5318584A (en) * | 1992-04-13 | 1994-06-07 | Boehringer Mannheim Gmbh | Blood lancet device for withdrawing blood for diagnostic purposes |
US6332871B1 (en) * | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US6749618B2 (en) * | 1999-10-19 | 2004-06-15 | Therasense, Inc. | Lancing device and method of sample collection |
US20050011759A1 (en) * | 2000-03-02 | 2005-01-20 | Moerman Piet H. C. | Combined lancet and electrochemical analyte-testing apparatus |
US6589260B1 (en) * | 2000-05-26 | 2003-07-08 | Roche Diagnostics Corporation | System for withdrawing body fluid |
US20080021494A1 (en) * | 2000-05-26 | 2008-01-24 | Guenther Schmelzeisen-Redeker | System for withdrawing body fluid |
US6561989B2 (en) * | 2000-07-10 | 2003-05-13 | Bayer Healthcare, Llc | Thin lance and test sensor having same |
US20030191415A1 (en) * | 2001-03-29 | 2003-10-09 | Piet Moerman | Integrated sample testing meter |
US20040215224A1 (en) * | 2001-07-19 | 2004-10-28 | Tetsuya Sakata | Piercing device |
US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US20050177071A1 (en) * | 2002-09-05 | 2005-08-11 | Hiroshi Nakayama | Invasive appliance |
US20040138588A1 (en) * | 2002-11-06 | 2004-07-15 | Saikley Charles R | Automatic biological analyte testing meter with integrated lancing device and methods of use |
US20070016103A1 (en) * | 2004-03-06 | 2007-01-18 | Irio Calasso | Body fluid sampling device |
US20060036187A1 (en) * | 2004-06-30 | 2006-02-16 | Hester Vos | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US20070293882A1 (en) * | 2004-12-02 | 2007-12-20 | Herbert Harttig | Pricking device for taking blood |
US20060155317A1 (en) * | 2004-12-10 | 2006-07-13 | Hans List | Lancet device for generating a puncture wound, and lancet drive assembly |
US20090275860A1 (en) * | 2005-03-31 | 2009-11-05 | Terumo Kabushiki Kaisha | Centesis Instrument |
US20070004990A1 (en) * | 2005-06-23 | 2007-01-04 | Michael Kistner | Hand-held instrument for the analysis of body fluids |
US20070060843A1 (en) * | 2005-08-29 | 2007-03-15 | Manuel Alvarez-Icaza | Method for lancing a target site with applied pressure sensing |
US20070060844A1 (en) * | 2005-08-29 | 2007-03-15 | Manuel Alvarez-Icaza | Applied pressure sensing cap for a lancing device |
US20070060842A1 (en) * | 2005-08-29 | 2007-03-15 | Manuel Alvarez-Icaza | Lancing cap kit applied pressure sensing cap |
US20080262387A1 (en) * | 2005-10-08 | 2008-10-23 | Hans List | Puncturing system |
US7955271B2 (en) * | 2006-10-13 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
US20090192409A1 (en) * | 2008-01-28 | 2009-07-30 | Daniel Wong | Rapid blood expression and sampling |
US20110270129A1 (en) * | 2008-10-29 | 2011-11-03 | Roche Diagnostics Operations, Inc. | Instrument and system for producing a sample of a body liquid and for analysis thereof |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015530149A (en) * | 2012-08-27 | 2015-10-15 | ファセット テクノロジーズ エルエルシーFacet Technologies, LLC | Twist loading mechanism of puncture device |
US11399755B2 (en) | 2016-08-24 | 2022-08-02 | Becton, Dickinson And Company | Device for obtaining a blood sample |
US11771352B2 (en) | 2016-08-24 | 2023-10-03 | Becton, Dickinson And Company | Device for the attached flow of blood |
US20180125400A1 (en) * | 2016-11-04 | 2018-05-10 | Apex Biotechnology Corp. | Glucose measuring device and apparatus |
CN112515669A (en) * | 2020-11-24 | 2021-03-19 | 为康(苏州)基因科技有限公司 | Gene detection quick sampling device |
Also Published As
Publication number | Publication date |
---|---|
US9186104B2 (en) | 2015-11-17 |
US20130237881A1 (en) | 2013-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2685386C (en) | Instrument and system for producing a sample of a body liquid and for analysis thereof | |
US9186104B2 (en) | Instruments and system for producing a sample of a body fluid and for analysis thereof | |
EP2548508B1 (en) | Instrument and system for producing a sample of a body liquid and for analysis thereof | |
US6589260B1 (en) | System for withdrawing body fluid | |
AU2011205171B2 (en) | Instrument and system for producing a sample of a body liquid and for analysis thereof | |
CN116849648A (en) | Needle placement structure capable of being reused |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS GMBH;REEL/FRAME:023537/0333 Effective date: 20070531 Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PATEL, PAUL;REEL/FRAME:023537/0393 Effective date: 20070507 Owner name: ROCHE DIAGNOSTICS GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KRAEMER, UWE;ZIMMER, VOLKER;ROEDEL, WOLFGANG;AND OTHERS;SIGNING DATES FROM 20070515 TO 20070524;REEL/FRAME:023539/0075 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ROCHE DIABETES CARE, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:036008/0670 Effective date: 20150302 |